Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.40    -2.00 (-1.17%)
Bid:
169.00
Ask:
170.00
Spread: 1.00 (0.592%)
Market Cap: £206.65m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Director Declaration

19 Jun 2025 14:30

RNS Number : 6276N
SThree plc
19 June 2025
Β 

19 June 2025

Β 

Β 

SThree plc

Β 

(the "Company")

Β 

Appointment of Senior Independent Director and changes in Directors' Responsibilities

Β 

As previously announced on 24 January 2025, having served as a non-executive director for nineyears, Denise Collis will be retiring from the Board on 30 June 2025.

In accordance with UKLR 6.4.6, SThree plc, the global STEM workforce consultancy, todayannounces that, with effect from 1 July 2025, Imogen Joss, who was appointed to the Board in December 2022, will become Senior Independent Director and Chair of the Remuneration Committee and Sanjeevan Bala, who was appointed to the Board in April 2024, will become Employee Engagement NED.

James Bilefield, Chair, said:

"I am immensely grateful to Denise for her significant contribution and dedication since her appointment. In addition to successfully discharging her responsibilities as our Senior Independent Director and Remuneration Committee Chair, Denise fully embraced the role of being our first Employee Engagement NED and has been a champion of and mentor to many of our colleagues in the business. I look forward to working with Imogen and Sanjeevan in their new roles."

Β 

Β 

Enquiries:

Β 

Β 

Β 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

Β 

Β 

Β via Alma

Alma Strategic Communications

+44 20 3405 0205

Β 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

Β 

Β 

Β 

Notes to editors

SThree plc brings skilled people together to build the future. We are the global STEM workforce consultancy, placing highly skilled, STEM specialist workers in the industries where they are needed most. We advise businesses, build expert teams, and deliver project solutions for our clients. With more than 38 years of experience in pure-play STEM and a global team with local expertise across 11 countries, we cover high-demand skills across Engineering, Life Sciences and Technology roles.

Β 

We provide permanent and flexible contract talent to a diverse base of around 6,000 clients. By combining advanced technology with expertise, we push beyond traditional boundaries to deliver tailored solutions, leveraging data and insight from our world-class operating platform.

Β 

Outpace tomorrow, together

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RDNFLMJTMTMBBRA
Date   Source Headline
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20259:59 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSFY24 Final Results
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 202510:10 amRNSDirectorate Change
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20253:28 pmRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20254:05 pmRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSCommencement of Share Buyback
17th Dec 20249:11 amRNSDirector/PDMR Shareholding
12th Dec 20244:49 pmRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSTrading Update
10th Dec 20241:15 pmRNSDirector/PDMR Shareholding
19th Nov 20243:01 pmRNSHolding(s) in Company
14th Nov 202412:30 pmRNSDirector/PDMR Shareholding
13th Nov 202410:05 amRNSDirector/PDMR Shareholding
1st Nov 20249:28 amRNSTotal Voting Rights
14th Oct 20245:19 pmRNSDirector/PDMR Shareholding
1st Oct 202410:10 amRNSTotal Voting Rights
25th Sep 20243:07 pmRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSFY24 Q3 Trading Update
16th Sep 20243:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.